Patent Docs: Mergers and Acquisitions Are Preferred Over IPO's

Patent Docs: Mergers and Acquisitions Are Preferred Over IPO's: "The biotech industry needs lots of capital for research, new product development, and lots of funds for daily operations. The current trend of mergers and acquisitions in the biotech industry arises in order to satisfy the needs of the industry. Many biotech firms have promising technologies and low stock prices, making such firms excellent takeover candidates. For large firms, mergers address excess capacity resulting from anticipated patent expirations and gaps in product pipelines. For small firms, mergers are excellent exit strategies and opportunities to have access to larger markets and more money."